Literature DB >> 15479439

Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.

Roberta L Richards1, Mangala Rao, Thomas C Vancott, Gary R Matyas, Deborah L Birx, Carl R Alving.   

Abstract

Protective or therapeutic immunity against HIV infection is currently believed to require both antibody and CTL responses against the envelope protein. In the present study, the adjuvant activity of a unique oil-in-water emulsion, in which liposomes containing lipid A (LA) and encapsulated antigen served as the emulsifying agent, was examined in mice using oligomeric gp140 (ogp140) derived from the HIV-1 envelope as the antigen. Emulsions rendered either highly stable or unstable by altering the ratio of liposomes to oil were used to examine the effect of stability of the emulsion on adjuvant activity. Stable and unstable emulsions had similar potencies for inducing both IgG antibodies to ogp140 and antigen-specific T-lymphocyte proliferation. Stable emulsions, but not unstable emulsions, induced antigen-specific CTL responses, possibly because of the depot effect of the stable emulsions. Furthermore, stable emulsions induced lower IgG2a/IgG1 ratios than the unstable emulsions. We conclude that stable liposomal oil-in-water emulsions provide an effective means of obtaining both antibody and CTL responses against an HIV envelope antigen. Copyright 2004 Australasian Society for Immunology Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479439     DOI: 10.1111/j.0818-9641.2004.01282.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  5 in total

1.  Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.

Authors:  Stacey L Demento; Weiguo Cui; Jason M Criscione; Eric Stern; Jacob Tulipan; Susan M Kaech; Tarek M Fahmy
Journal:  Biomaterials       Date:  2012-04-06       Impact factor: 12.479

2.  Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.

Authors:  Kristina K Peachman; Qin Li; Gary R Matyas; Sathish B Shivachandra; Julie Lovchik; Rick C Lyons; Carl R Alving; Venigalla B Rao; Mangala Rao
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

3.  Effect of alum co-adjuvantation of oil adjuvant vaccine on emulsion stability and immune responses against haemorhagic septicaemia in mice.

Authors:  Sujeet Kumar; Vinod Kumar Chaturvedi; Bablu Kumar; Pankaj Kumar; Sudha Rani Somarajan; Anil Kumar Mishra; Bhaskar Sharma
Journal:  Iran J Microbiol       Date:  2015-04

Review 4.  Harnessing nanoparticles for immune modulation.

Authors:  Daniel R Getts; Lonnie D Shea; Stephen D Miller; Nicholas J C King
Journal:  Trends Immunol       Date:  2015-06-15       Impact factor: 16.687

5.  Application of Liposome Encapsulating Lactobacillus curvatus Extract in Cosmetic Emulsion Lotion.

Authors:  Hyo-Tae Kim; Jiseon Lee; Yeon-Ji Jo; Mi-Jung Choi
Journal:  Materials (Basel)       Date:  2021-12-09       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.